Calcium atorvastatin

Apejuwe kukuru:

Orukọ API Itọkasi Sipesifikesonu US DMF EU DMF CEP
Calcium atorvastatin Hypercholesterolemia Ninu Ile / CEP Ọdun 29057 CEP 2015-034


Alaye ọja

ọja Tags

Apejuwe ọja

abẹlẹ

Calcium Atorvastatin jẹ oludena agbara ti HMG-CoA reductase pẹlu iye IC50 ti 150 nM.
HMG-CoA reductase jẹ enzymu bọtini ti ọna mevalonate eyiti o ṣe agbejade idaabobo awọ.HMG-CoA jẹ henensiamu aropin-oṣuwọn ati pe o ṣe pataki fun idinku awọn ipele idaabobo awọ ẹjẹ.HMG-CoA reductase wa ninu reticulum endoplasmic ati pe o ni awọn ibugbe transmembrane mẹjọ ninu.Awọn oludena ti HMG-CoA reductase le fa ikosile LDL (lipoprotein iwuwo kekere) awọn olugba ninu ẹdọ.O yori si alekun awọn ipele catabolism ti pilasima LDL ati dinku ifọkansi ti idaabobo awọ pilasima eyiti o jẹ ipinnu pataki ti atherosclerosis.HMG-CoA reductase ṣe ipa pataki ninu iṣelọpọ idaabobo awọ.HMG-CoA jẹ ibi-afẹde kan fun awọn oogun ti o dinku idaabobo awọ.HMG-CoA reductase tun jẹ enzymu pataki fun idagbasoke.Iṣẹ ṣiṣe ti HMG-CoA reductase ni ibatan si awọn abawọn iṣilọ sẹẹli germ.Idilọwọ iṣẹ ṣiṣe rẹ le ja si iṣọn-ẹjẹ inu cerebral [1].
Atorvastatin jẹ inhibitor HMG-CoA reductase pẹlu iye IC50 ti 154 nM.O munadoko ninu itọju awọn dyslipidemia kan ati hypercholesterolemia[1].Itọju Atorvastatin ni 40 miligiramu dinku idaabobo awọ lapapọ ti 40% lẹhin awọn ọjọ 40.A tun lo lati tọju awọn alaisan iṣọn-ẹjẹ tabi ọpọlọ pẹlu awọn ipele idaabobo awọ deede.[2]Atorvastatin tun dinku apheresis lipoprotein iwuwo kekere ninu awọn alaisan nipasẹ jijẹ ikosile awọn olugba LDL.
O jẹ metabolized si awọn metabolites pupọ eyiti o ṣe pataki fun ipa awọn iṣe itọju ailera nipasẹ CYP3A4 (cytochrome P450 3A4).[3]
Awọn itọkasi:
[1].van Dam M, Zwart M, de Beer F, Smelt AH, Prins MH, Trip MD, Havekes LM, Lansberg PJ, Kastelein JJ: Lilo igba pipẹ ati ailewu ti atorvastatin ni itọju iru III ti o nira ati apapọ dyslipidemia.Ọkàn 2002, 88 (3): 234-238.
[2].Sever PS, Dahlof B, Poulter NR, Wedel H, Beevers G, Caulfield M, Collins R, Kjeldsen SE, Kristinsson A, McInnes GT et al: Idena ti iṣọn-alọ ọkan ati awọn iṣẹlẹ ikọlu pẹlu atorvastatin ni awọn alaisan haipatensonu ti o ni apapọ tabi isalẹ ju. Awọn ifọkansi idaabobo awọ aropin, ninu Idanwo Awọn abajade ọkan ọkan Anglo-Scandinavian--Lipid Lowering Arm (ASCOT-LLA): idanwo iṣakoso aileto ti ọpọlọpọ aarin.Lancet 2003, 361 (9364): 1149-1158.
[3].Lennernas H: awọn oogun elegbogi ti atorvastatin.Clin Pharmacokinet 2003, 42 (13): 1141-1160.

Ilana kemikali

Atorvastatin-Calcium

Ijẹrisi

2018 GMP-2
原料药GMP证书201811(captopril ,thalidomide etc)
GMP-of-PMDA-in-Chanyoo-平成28年08月03日 Nantong-Chanyoo-Pharmatech-Co
FDA-EIR-Letter-201901

Ìṣàkóso didara

Quality management1

Igbero18Awọn iṣẹ akanṣe Igbelewọn Iṣeduro Didara eyiti o ti fọwọsi4, ati6ise agbese ni o wa labẹ alakosile.

Quality management2

Eto iṣakoso didara agbaye ti ilọsiwaju ti fi ipilẹ to lagbara fun tita.

Quality management3

Abojuto didara n ṣiṣẹ nipasẹ gbogbo igbesi aye ọja lati rii daju didara ati ipa itọju ailera.

Quality management4

Ẹgbẹ Aṣoju Iṣeduro Ọjọgbọn ṣe atilẹyin awọn ibeere didara lakoko ohun elo ati iforukọsilẹ.

gbóògì isakoso

cpf5
cpf6

Koria Countec Bottled Packaging Line

cpf7
cpf8

Taiwan CVC Laini Iṣakojọpọ Igo

cpf9
cpf10

Italy CAM Board Packaging Line

cpf11

German Fette Compacting Machine

cpf12

Japan Viswill Tablet Oluwari

cpf14-1

DCS Iṣakoso yara

ALÁGBẸ́NI

International ifowosowopo
International cooperation
Abele ifowosowopo
Domestic cooperation

  • Ti tẹlẹ:
  • Itele:

  • Kọ ifiranṣẹ rẹ nibi ki o si fi si wa

    Awọn ẹka ọja